PLASMODIUM FALCIPARUM MALARIA
Clinical trials for PLASMODIUM FALCIPARUM MALARIA explained in plain language.
Never miss a new study
Get alerted when new PLASMODIUM FALCIPARUM MALARIA trials appear
Sign up with your email to follow new studies for PLASMODIUM FALCIPARUM MALARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New malaria-blocking vaccines tested in kids and adults
⭐️ VACCINE ⭐️ OngoingThis study tests two experimental vaccines designed to stop the spread of malaria from person to person. They are given to healthy volunteers aged 5 to 45 in Burkina Faso, where malaria is common. The goal is to check if the vaccines are safe and trigger a strong immune response.
Matched conditions: PLASMODIUM FALCIPARUM MALARIA
Phase: PHASE1, PHASE2 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:53 UTC
-
Malaria-Fighting study in laos pulled before it started
Prevention TerminatedThis study aimed to see if a more thorough approach to finding malaria cases in high-risk villages and among forest workers could reduce the spread of two types of malaria in southern Laos. The plan was to compare this enhanced method to standard care over 18 months. However, the…
Matched conditions: PLASMODIUM FALCIPARUM MALARIA
Phase: NA • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated May 17, 2026 13:56 UTC